<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00641433</url>
  </required_header>
  <id_info>
    <org_study_id>ORT 014</org_study_id>
    <nct_id>NCT00641433</nct_id>
  </id_info>
  <brief_title>Topical Collagen-Silver Versus Standard Care Following Removal of Ingrown Nails</brief_title>
  <official_title>Topical Collagen-Silver Versus Standard Care Following Phenol Ablation of Ingrown Nails: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rosalind Franklin University of Medicine and Science</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rosalind Franklin University of Medicine and Science</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study's purpose is to prospectively determine whether topical therapy with an oxidized&#xD;
      regenerated cellulose collagen-silver compound is more effective than the current standard of&#xD;
      topical antibiotic therapy for care following the removal of an ingrown toenail. Eighty adult&#xD;
      patients with ingrown toenails will be recruited. Each patient will randomly be assigned to&#xD;
      apply either topical silver sulfadiazine cream (standard antibiotic) or the novel&#xD;
      collagen-silver compound to their nail bed daily, following removal of the ingrown portion of&#xD;
      nail. Patients will return for follow up visits weekly, until healing has occurred or twelve&#xD;
      weeks have passed. Healing will be defined as resolution of drainage and inflammatory changes&#xD;
      surrounding the nail border.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2005</start_date>
  <completion_date type="Anticipated">May 2008</completion_date>
  <primary_completion_date type="Anticipated">May 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>time to healing</measure>
    <time_frame>weekly</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time to return to regular shoe gear</measure>
    <time_frame>weekly</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days unable to work</measure>
    <time_frame>weekly</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Ingrown Nail</condition>
  <arm_group>
    <arm_group_label>experimental</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will daily dress their nail bed with oxidized regenerated cellulose collagen-silver, until healing occurs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topical silver sulfadiazine cream will be applied daily to the wound bed until healing has occured.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>oxidized regenerated cellulose collagen-silver</intervention_name>
    <description>Wound dressed daily with oxidized regenerated cellulose collagen-silver matrix.</description>
    <arm_group_label>experimental</arm_group_label>
    <other_name>Prisma</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>topical silver sulfadiazine cream</intervention_name>
    <description>Cream will be applied to nailbed daily and dressed with a bandage until healing occurs.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Silvadene, Thermazene</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ingrown toenails will be defined as any incurvated nail border that digs into the skin&#xD;
             of the nail fold and causes pain and discomfort&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with immunocompromised states&#xD;
&#xD;
               -  chronic steroid use&#xD;
&#xD;
               -  diabetes mellitus&#xD;
&#xD;
               -  collagen vascular disease&#xD;
&#xD;
               -  HIV infection&#xD;
&#xD;
          -  Cellulitis proximal to the hallux interphalangeal joint or peripheral vascular disease&#xD;
             will be excluded&#xD;
&#xD;
          -  We will define peripheral vascular disease as the absence of one or more pedal pulses&#xD;
             or the presence of dystrophic changes to the integument&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David G Armstrong, DPM, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rosalind Franklin University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David G Armstrong, DPM, PhD</last_name>
    <phone>847-578-8440</phone>
    <email>david.armstrong@rosalindfranklin.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Scholl Foot and Ankle Center</name>
      <address>
        <city>North Chicago</city>
        <state>Illinois</state>
        <zip>60064</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ryan T Crews, MS</last_name>
      <phone>847-578-8437</phone>
      <email>ryan.crews@rosalindfranklin.edu</email>
    </contact>
    <investigator>
      <last_name>David Armstrong, DPM, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Wu, DPM, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Wrobel, DPM, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Preofessional Education and Research Institutue</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charles Zelen, DPM</last_name>
      <phone>540-725-5027</phone>
      <email>cmzelen@periedu.com</email>
    </contact>
    <investigator>
      <last_name>Charles Zelen, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <study_first_submitted>March 18, 2008</study_first_submitted>
  <study_first_submitted_qc>March 18, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2008</study_first_posted>
  <last_update_submitted>March 18, 2008</last_update_submitted>
  <last_update_submitted_qc>March 18, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2008</last_update_posted>
  <responsible_party>
    <name_title>Office of Sponsored Research</name_title>
    <organization>Rosalind Franklin University of Medicine and Science</organization>
  </responsible_party>
  <keyword>chemocautery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nails, Ingrown</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sulfadiazine</mesh_term>
    <mesh_term>Silver Sulfadiazine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

